Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

RevOpsis Therapeutics

Request full access

Innovative bispecific platform targeting eye diseases to prevent blindness with advanced therapeutic agents

Springfield, United StatesFounded 2022Biotech & Life Sciences

About RevOpsis Therapeutics

RevOpsis Therapeutics is a biotechnology company dedicated to addressing blindness through innovative treatments. Leveraging a proprietary bispecific platform, the company develops fully human, antibody-like proteins designed to target multiple clinically validated biological pathways. This approach aims to improve disease outcomes and extend disease remission for a broad range of eye diseases. RevOpsis Therapeutics primarily serves patients suffering from various eye conditions, operating within the healthcare and biotechnology markets. The business model revolves around the research, development, and commercialization of therapeutic agents, generating revenue through product sales and potential partnerships with other healthcare entities.

Source: Dealroom company data

At a glance

Status
Operational
Employees
4
Open positions
None listed
Dealroom signal
56.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Sep 2025 $0 — ExSight Ventures ↗
DEBT✓Debt Apr 2024 $7.5M — Undisclosed ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

RevOpsis Therapeutics website traffic

Latest recorded traffic for RevOpsis Therapeutics is 160 monthly website visits, down 85.5% over the last three months. RevOpsis Therapeutics's team grew 0% over the past year.

Latest monthly visits160 3-month web change-85.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

RevOpsis Therapeutics in the Springfield ecosystem

Live from Dealroom

The RevOpsis Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • ExSight Ventures

Other known investors1 additional known investor

  • University of Colorado
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about RevOpsis Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RevOpsis Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.